Moreover, we have reported a combined effect of the inhibitors of USP7 and PARP enzymes in the treatment of lung neuroendocrine tumor cells expressing USP7 and CCDC6 proteins [23]. Here, USP7 is linked to lung neuroendocrine neoplasm.